Similar companies
Company | Transaction Value | |
---|---|---|
Clover HealthCLOV |
$4.1M | |
MetLifeMET |
-$102M | |
AflacAFL |
-$276M | |
ProgressivePGR |
-$1.42B | |
CenteneCNC |
$89M |
Insider Transactions
Name | Transaction Date | Sold / Bought | Shares | Price | Value |
---|---|---|---|---|---|
Eckert William James IV | Dec 23, 2024 | Sell | 1,700 | $46.68 | $79,000 |
Lane Nick | Dec 18, 2024 | Sell | 9,098 | $46.4802 | $420,000 |
Lane Nick | Dec 18, 2024 | Sell | 5,500 | $45.904 | $250,000 |
Lane Nick | Dec 18, 2024 | Sell | 5,402 | $44.685 | $240,000 |
Lane Nick | Dec 18, 2024 | Sell | 2,320 | $46.4903 | $110,000 |
Lane Nick | Dec 18, 2024 | Sell | 1,411 | $44.676 | $63,000 |
Lane Nick | Dec 18, 2024 | Sell | 1,269 | $45.8995 | $58,000 |
Pearson Mark | Dec 16, 2024 | Sell | 20,000 | $47.3066 | $950,000 |
Pearson Mark | Dec 16, 2024 | Sell | 10,000 | $47.3073 | $470,000 |
HURD JEFFREY J | Dec 16, 2024 | Sell | 6,666 | $47.3081 | $320,000 |
MacKay Craig C | Nov 19, 2024 | Sell | 1,000 | $46.4094 | $46,000 |
Pearson Mark | Nov 15, 2024 | Sell | 20,000 | $47.4259 | $950,000 |
Pearson Mark | Nov 15, 2024 | Sell | 10,000 | $47.4298 | $470,000 |
HURD JEFFREY J | Nov 8, 2024 | Sell | 6,666 | $47.533 | $320,000 |
Pearson Mark | Oct 15, 2024 | Sell | 20,000 | $44.3995 | $890,000 |
Pearson Mark | Oct 15, 2024 | Sell | 10,000 | $44.398 | $440,000 |
Eckert William James IV | Sep 19, 2024 | Sell | 3,500 | $42.416 | $150,000 |
Pearson Mark | Sep 16, 2024 | Sell | 20,000 | $40.7743 | $820,000 |
Pearson Mark | Sep 16, 2024 | Sell | 10,000 | $40.7777 | $410,000 |
Pearson Mark | Aug 29, 2024 | Sell | 20,000 | $42.1973 | $840,000 |
Pearson Mark | Aug 29, 2024 | Sell | 10,000 | $42.2026 | $420,000 |
HURD JEFFREY J | Jul 15, 2024 | Sell | 9,969 | $43.0925 | $430,000 |
HURD JEFFREY J | Jun 14, 2024 | Sell | 9,969 | $39.622 | $390,000 |
HURD JEFFREY J | May 15, 2024 | Sell | 9,969 | $40.4198 | $400,000 |
BERNSTEIN SETH P | May 2, 2024 | Sell | 152,473 | $38.0569 | $5.8M |
Pearson Mark | Apr 15, 2024 | Sell | 15,800 | $36.0554 | $570,000 |
Pearson Mark | Apr 15, 2024 | Sell | 8,046 | $36.0729 | $290,000 |
Pearson Mark | Apr 15, 2024 | Sell | 4,200 | $36.913 | $160,000 |
Pearson Mark | Apr 15, 2024 | Sell | 1,954 | $36.933 | $72,000 |
HURD JEFFREY J | Apr 15, 2024 | Sell | 7,763 | $36.0466 | $280,000 |
HURD JEFFREY J | Apr 15, 2024 | Sell | 2,206 | $36.9036 | $81,000 |
Pearson Mark | Apr 1, 2024 | Sell | 20,000 | $37.6636 | $750,000 |
Pearson Mark | Apr 1, 2024 | Sell | 10,000 | $37.6631 | $380,000 |
SCOTT BERTRAM L | Mar 18, 2024 | Sell | 7,000 | $35.2873 | $250,000 |
HURD JEFFREY J | Mar 15, 2024 | Sell | 9,969 | $35.3188 | $350,000 |
Pearson Mark | Mar 1, 2024 | Sell | 40,000 | $33.7692 | $1.4M |
Pearson Mark | Mar 1, 2024 | Sell | 20,000 | $33.77 | $680,000 |
HURD JEFFREY J | Feb 29, 2024 | Sell | 9,969 | $34.2787 | $340,000 |
Stonehill Charles G.T. | Feb 21, 2024 | Sell | 5,000 | $34.0243 | $170,000 |
Lane Nick | Feb 15, 2024 | Sell | 10,000 | $34.2728 | $340,000 |
Pearson Mark | Feb 1, 2024 | Sell | 39,600 | $32.3753 | $1.3M |
Pearson Mark | Feb 1, 2024 | Sell | 20,000 | $32.3779 | $650,000 |
Pearson Mark | Feb 1, 2024 | Sell | 400 | $32.8 | $13,000 |
Lane Nick | Jan 16, 2024 | Sell | 5,000 | $32.2874 | $160,000 |
Pearson Mark | Jan 2, 2024 | Sell | 60,000 | $33.0686 | $2M |
Lane Nick | Dec 22, 2023 | Sell | 5,000 | $33.3018 | $170,000 |
Kaye Daniel G | Dec 20, 2023 | Sell | 4,845 | $33.85 | $160,000 |
Eckert William James IV | Dec 14, 2023 | Sell | 7,000 | $34.59 | $240,000 |
Pearson Mark | Dec 1, 2023 | Sell | 60,000 | $30.6017 | $1.8M |
Matus Kristi Ann | Mar 24, 2023 | Sell | 10,615 | $23.3916 | $250,000 |
Matus Kristi Ann | Mar 24, 2023 | Sell | 8,682 | $23.2746 | $200,000 |
Eckert William James IV | Mar 22, 2023 | Sell | 8,100 | $25.3807 | $210,000 |
Raju Robin M | Mar 15, 2023 | Buy | 2,096 | $23.7768 | $50,000 |
What's the latest insider transaction for Axa Equitables?
The most recent insider transaction for Axa Equitables was conducted by Eckert William James IV, who sold 1,700 shares on December 23, 2024 at a price of $46.68 per share.
Which insider bought the most EQH stock over the last two years?
Raju Robin M has bought the most EQH stock in the last 2 years, with a total value of $50,000.
Which insider has sold the most EQH stock over the last two years?
Pearson Mark has sold the most EQH stock in the last 2 years, with a total value of $17M.
What is the total value of insider transactions for Axa Equitables (EQH) in the last 2 years?
The total value of insider transactions for Axa Equitables in the last 2 years is negative, amounting to -$29M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on Axa Equitables' market confidence?
Over the last 2 years, insider transactions for Axa Equitables have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.